JPMorgan, Leerink and Guggenheim are acting as joint book running managers for the offering.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on COGT:
- Cogent Biosciences offers to sell $150M in common stock
- Cogent Biosciences price target raised to $22 from $12 at H.C. Wainwright
- Cogent Biosciences price target raised to $9 from $7 at Baird
- Promising Outlook for Cogent Biosciences: Bezuclastinib’s Potential in Systemic Mastocytosis and Beyond
- Cogent Biosciences Receives Buy Rating on Promising Trial Results and Market Potential